2. Emplacement (adresse postale)
Belasis Avenue, Billingham, TS23 1LH, UK
3. Description générale des types de maladie visés
Coronavirus disease (COVID-19)
[Licensed for bulk drug substance manufacturing and testing via MHRA manufacturer’s authorisations MIA 18480 and MIA (IMP) 18480].